RRML - Biomarkers of acute kidney injury: a concise review of current literature
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12


Advanced search


Top 10 downloaded articles
- November 2024 -
 
Epidemiological data and antif... 1
The direct deleterious effect ... 1

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 32(4)/2024 DOI:10.2478/rrlm-2024-0028
XML
TXT

Research article

Biomarkers of acute kidney injury: a concise review of current literature

Ileana Adela Văcăroiu, Andra Elena Balcangiu-Stroescu, Larisa Florina Șerban-Feier, Elena Cuiban, Ioana Sorina Simion, Iulia Ioana Stănescu-Spînu, Daniela Miricescu, Maria Greabu, Liviu Vasile Chiperi, Daniela Gabriela Bălan

Correspondence should be addressed to: Andra Elena Balcangiu-Stroescu

Abstract:

Background: Acute kidney injury (AKI), a medical condition associated with increased hospitalization rates which requires interdisciplinary management, is a major health concern because of the burden it places on the health systems of different countries. Biomarkers represent the focus of recent years in furthering the early diagnosis of AKI, providing new opportunities for correct prophylaxis or early therapeutic intervention so that the evolution of patients with this pathology is favorable and the risk of life-threatening complications is negligible. Methods: We performed an extensive literature search on PubMed and ScienceDirect databases, using keywords related to biomarkers for AKI. We searched for acute kidney injury (AKI), cystatin C (CYS-C), galectin-3 (GAL-3), kidney injury molecule-1 (KIM-1), neutrophil-gelatinase-associated lipocalin (NGAL), interleukin-8 (IL-8), and liver-type fatty acid-binding protein (L-FABP). We included a high number of papers, with an emphasis on more recent publications. Results: Studies that analyzed the biomarkers for AKI show that CYS-C, GAL-3, KIM-1, NGAL, IL-8, calprotectin, and proteinuria were noted as potential biomarkers for early diagnosis of AKI. Conclusions: Biomarkers represent the focus of recent years in furthering an early diagnosis of AKI, providing new opportunities for correct prophylaxis or early therapeutic intervention.

Keywords: acute kidney injury (AKI), biomarkers, cystatin C (CYS-C), liver-type fatty acid-binding protein (L-FABP), neutrophil gelatinase-associated lipocalin (NGAL)

Received: 28.6.2024
Accepted: 26.9.2024
Published: 7.10.2024

 
  PDF Download full text PDF
(683 KB)
     
 
How to cite
Văcăroiu IA, Balcangiu-Stroescu AE, Șerban-Feier LF, Cuiban E, Simion IS, Stănescu-Spînu II, et al. Biomarkers of acute kidney injury: a concise review of current literature. Rev Romana Med Lab. 2024;32(4):305-13. DOI:10.2478/rrlm-2024-0028